Cognitive Decline and Neurodegenerative Conditions Cognitive decline and neurodegenerative conditions show substantial preclinical evidence across multiple pathologies: Stroke models: BPC-157 given during reperfusion counteracted neuronal damage and produced full functional recovery in spatial memory, motor coordination, and balance tests Parkinsons models: MPTP-induced models showed reduced motor symptoms (tremor, rigidity, akinesia), protection of nigrostriatal dopaminergic neurons, and near-complete prevention of mortality Multiple sclerosis models: Cuprizone-induced demyelination resulted in significantly less brain damage and reduced clinical abnormalities when BPC-157 was given in drinking water or intragastrically Traumatic brain injury: Falling weight model studies demonstrated reduced hemorrhage, decreased brain lacerations and edema, and improved early outcomes These diverse models share common mechanisms
Data in Figs
Meningkatkan sensitivitas insulin Resistensi insulin dapat menyebabkan perkembangan pada diabetes tipe 2
(5) D A Sibarov, A B Volnova, D S Frolov, and A D Nozdrachev (2007) Effects of intranasal administration of epitalon on neuron activity in the rat neocortex Neuroscience and Behavioral Physiology, 2007 Nov, Volume 37 (Issue 9), Pages 889-93
Temperature stability and product degradation IGF-1 LR3's stability profile explains why so many users report disappointing results